Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
12/2005
12/08/2005WO2005116034A1 Tetraazabenzo[e]azulene derivatives and analogs thereof
12/08/2005WO2005116033A1 Immuno inhibitory heterocyclic compounds
12/08/2005WO2005116032A2 Reverse-turn mimetics and method relating thereto
12/08/2005WO2005116014A1 Proline derivatives and their use as dipeptidyl peptidase iv inhibitors
12/08/2005WO2005115990A1 Cinnamide compound
12/08/2005WO2005115983A1 Aryl sulfonamide and sulfonyl compounds as modulators of ppar and methods of treating metabolic disorders
12/08/2005WO2005115977A1 Pyrrolidine derivatives as cb1-receptor antagonists
12/08/2005WO2005115399A2 Imidazopyrazines, imidazopyridines, ans imidazopyrimidines as crf1 receptor ligands
12/08/2005WO2005115398A2 Hiv integrase inhibitors
12/08/2005WO2005115361A2 Androgen receptor modulators and method of treating disease using the same
12/08/2005WO2005115145A2 Quinone substituted quinazoline and quinoline kinase inhibitors
12/08/2005WO2005087770A3 5,6-dihydrocarbyl-7-amino-triazolopyrimidines, method for their production, their use for controlling pathogenic fungi and agents containing said compounds
12/08/2005WO2005067936A3 Methods for the production of sildenafil base and citrate salt
12/08/2005WO2004098589A8 4- bromo - 5 - (2- chloro - benzoylamino) - 1h - pyrazole - 3 - carboxylic acid amide derivatives and related compounds as bradykinin b1 receptor antagonists for the treatment of inflammatory diseases
12/08/2005WO2004093805A3 Selective spirocyclic glucocorticoid receptor modulators
12/08/2005WO2004093798A3 Quinoxalinyl macrocyclic hepatitis c serine protease inhibitors
12/08/2005US20050272799 Fused Heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
12/08/2005US20050272798 Analogues of rachelmycin and the duocarmycins that are potent cytotoxins containing a benzodipyrrole or naphthopyrrole ring; anticancer agents
12/08/2005US20050272791 Lung melanoma metastasis, rheumatoid arthritis, 1-isopropylsulfonyl-2-amino-6-(2-(2,6-difluorophenyl)-5-(phenyl)-imidazol-4-yl)-benzimidazole
12/08/2005US20050272753 signal transducer and activator of transcription-6 inhibitors; asthma, COPD, respiratory, inflammatory and allergic diseases; compounds have less suppressive effect on immunological functions; 4-[(2,5 -difluorobenzyl) amino]-2-[(4-morpholin-4-ylphenyl)amino]pyrimidine-5 -carboxamide
12/08/2005US20050272749 5-Alkyl-7-aminotriazolopyrimidines, methods and intermediary product necessary for the production thereof, agents containing said compounds and the use thereof for fighting against harmful mushrooms
12/08/2005US20050272748 2-Mercapto-substituted triazolopyrimidines, methods for the production thereof, the use of the same for controlling patogenic fungi, and agents containing said compounds
12/08/2005US20050272745 Novel piperidine and piperazine derivatives
12/08/2005US20050272739 N-aryl diazaspiracyclic compounds and methods of preparation and use thereof
12/08/2005US20050272736 Tri- and bi-cyclic heteroaryl histamine-3 receptor ligands
12/08/2005US20050272735 1H-indazoles, benzothiazoles, 1,2-benzoisoxazoles, 1,2-benzoisothiazoles, and chromones and preparation and uses thereof
12/08/2005US20050272732 5-ethyl-imidazo (5,1-F) (1,2,4,) triazin-4 (3h)-ones as phosphodiesterase inhibitors
12/08/2005US20050272727 As antitumor and anticancer agents
12/08/2005US20050272676 Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
12/08/2005US20050271715 Conjugate having a cleavable linkage for use in a liposome
12/08/2005DE102005012143A1 Verfahren zur Herstellung eines Kontaktprodukts; A process for producing a contact product; Katalysatorkomponente zur Additionspolymerisation; A catalyst component for addition polymerization; Verfahren zur Herstellung eines Katalysators zur Additionspolymerisation und Verfahren zur Herstellung eines Additionspolymers A process for producing a catalyst for addition polymerization and process for producing an addition polymer
12/08/2005DE102004022897A1 Azinyl-imidazoazine Azinyl-imidazoazines
12/08/2005CA2568056A1 Tetraazabenzo[e]azulene derivatives and analogs thereof
12/08/2005CA2566942A1 Androgen receptor modulators and method of treating disease using the same
12/08/2005CA2566094A1 Cinnamide compound
12/08/2005CA2564638A1 Aryl sulfonamide and sulfonyl compounds as modulators of ppar and methods of treating metabolic disorders
12/08/2005CA2562693A1 Reverse-turn mimetics and method relating thereto
12/07/2005EP1602649A2 1,4,7,10-tetraazacyclododecane-1,4-diacetic acid derivatives as chelating agents
12/07/2005EP1601678A2 Fused pyrrole compounds
12/07/2005EP1601676A2 Fused imidazoles as transforming growth factor (tgf) inhibitors
12/07/2005EP1601673A1 Novel fused heterocycles and uses thereof
12/07/2005EP1601649A2 A1 adenosine receptor antagonists
12/07/2005EP1379528A4 Pyrazolopyrimidines as therapeutic agents
12/07/2005EP1199306B1 Biarylurea derivatives
12/07/2005EP1171442B1 Xanthine derivatives and analogs as cell signalling inhibitors
12/07/2005EP1155019B1 Substituted porphyrins and their therapeutic use
12/07/2005EP0957917B1 Vitronectin receptor antagonists
12/07/2005EP0949920B1 Highly selective butyrylcholinesterase inhibitors for the treatment and diagnosis of alzheimer's disease and dementias
12/07/2005CN1705672A New benzodioxino-isoindole derivatives, useful for treatment of cancer, are inhibitors of cell cycle
12/07/2005CN1705668A Heterocyclocarboxamide derivatives
12/07/2005CN1705667A New fused pyrrolo-carbazole or pyrido-pyrrolo-indole derivatives (i), useful for treating cancer
12/07/2005CN1704415A (Zinc) porphyrin - perylene diimide ( PDI) - C60 ternary system and its synthesis method
12/07/2005CN1230436C Imidazo[1,5,-a] pyrimido[5,4-d]benzazepine derivatives as GABAA receptor modulators
12/07/2005CN1230431C Arylmethylamine derivatives for use as tryptase inhibitors
12/07/2005CN1230403C Production of fluorine compounds
12/06/2005US6972331 Carboxy pyrrole, process of preparing and use as precursor
12/06/2005US6972328 can comprise DNA, RNA, PNA, or any combination or chimera thereof
12/06/2005US6972297 2-Hydroxy-mutilin carbamate derivatives for antibacterial use
12/06/2005CA2354606C Azabicycloalkane derivatives and therapeutic uses thereof
12/06/2005CA2188905C Process for the preparation of dihaloazolopyrimidines
12/01/2005WO2005113646A1 Deuterated polyimides and derivatives thereof
12/01/2005WO2005113562A1 Hiv integrase inhibitors: cyclic pyrimidinone compounds
12/01/2005WO2005113556A1 Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta
12/01/2005WO2005113555A1 Triazolopyrimidine compounds and their use for controlling pathogenic fungi
12/01/2005WO2005113554A2 Method of preparing 3-phenyl-2-[9h-purin-6-ylamino)-methyl]-3h-quinazolin-4-one and substituted and related compounds
12/01/2005WO2005113553A2 Azinyl imidazoazine and azinyl carboxamide
12/01/2005WO2005113536A2 Tri- and bi-cyclic heteroaryl histamine-3 receptor ligands
12/01/2005WO2005113526A2 Metabolites of 4-(3,4-dichloro-phenyl)-2-[2-(4-methyl-piperazin-1-yl)-benzylidene]-thiomorpholin-3-one
12/01/2005WO2005112938A2 Disalt inhibitors of il-12 production
12/01/2005WO2005095403A3 Macrocyclic compounds as inhibitors of viral replication
12/01/2005WO2005087771A3 5,6-dialkyl-7-amino-triazolopyrimidines, method for their production, their use for controlling pathogenic fungi and agents containing said compounds
12/01/2005WO2005077899A3 Amino-substituted tricyclic derivatives and methods of use
12/01/2005WO2005060963A8 Benzenesulfonylamino-pyridin-2-yl derivatives and related compounds as inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1 (11-beta-hsd-1) for the treatment of diabetes and obesity
12/01/2005US20050267304 Protein kinase inhibitors; astham; psoriasis; antiinflammatory agents; inflammatory bowel disorders
12/01/2005US20050267303 Cyclic indole and heteroindole derivatives and methods for making and using as pharmaceuticals
12/01/2005US20050267187 Reacting free hydroxyl-containing probucol or a derivative thereof (by which is meant a probucol compound with at least one substituent that is different from that on the parent probucol molecule but which maintains the two free hydroxyl groups) with a Grignard reagent or a lithium reagent
12/01/2005US20050267182 Urea derivatives as FLT-3 modulators
12/01/2005US20050267133 Pyrazolopyrimidines as kinase inhibitors
12/01/2005US20050267132 6-Hydroxy-2,5-dioxo-1,2,3,5-tetrahydro-imidazo[1, 2-a]pyrimidine-7-carboxylic amide derivatives; lymphadenopathy associated virus and human T-cell leukemia/lymphoma virus treatment; AIDS
12/01/2005US20050267131 Treatment of HIV integrase heterocycles for enzyme inhibitors and process of viricides
12/01/2005US20050267130 e.g. 2,3,4,5-tetrahydro-2-[2-[4-methoxy-7-(5-methyl-1H-1,2,4-triazol-1-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl]-1,2-dioxoethyl]-5-phenyl-1H-pyrido[4,3-b]indole; inhibit HIV entry by attaching to exterior viral envelop protein gp120 and interrupting viral entry process by interfering with cellular receptor CD4
12/01/2005US20050267116 Substituted hexahydropyrrolo[1,2-a]pyrazines, octahydropyrido[1,2-a]-pyrazines and decahydropyrazino[1,2-a]azepines
12/01/2005US20050267115 Melanin-concentrating hormone (MCH); for the treatment of metabolic disorders and/or eating disorders, such as obesity and diabetes, also drug dependencies, and urinary incontinence
12/01/2005US20050267112 intravenous or oral administration; hypotensive agents; enzyme inhibitors of cGMP-metabolizing phosphodiesterases
12/01/2005US20050267111 Pharmaceutical compositions and methods for use
12/01/2005US20050267110 Propane-1, 3-dione derivative
12/01/2005US20050267100 For therapy of obesity
12/01/2005US20050267019 Echinocandin derivatives, their method of preparation and their application as anti-fungal agents
12/01/2005DE102004024274A1 Verfahren zur Herstellung einer Lösung von reinem Triethylendiamin (TEDA) A process for preparing a solution of pure triethylenediamine (TEDA)
12/01/2005DE102004022970A1 Neue Imidazolderivate, deren Herstellung und deren Verwendung als Intermediate zur Herstellung von Arzneimitteln und Pestiziden New Imidazole derivatives, their preparation and their use as intermediates for the preparation of medicaments and pesticides,
12/01/2005CA2567487A1 Deuterated polyimides and derivatives thereof
12/01/2005CA2566755A1 Hiv integrase inhibitors: cyclic pyrimidinone compounds
12/01/2005CA2566074A1 Azinyl imidazoazine and azinyl carboxamide
12/01/2005CA2564076A1 Chemical linkers and conjugates thereof
11/2005
11/30/2005EP1599483A1 Exo-(t-butyl 2r(+))-2-amino-7-azabicyclo 2.2.1 heptane- 7-carboxylate, intermediates, and process to prepare and isolate them
11/30/2005EP1599482A1 Pyrazolo 1,5-a pyrimidine derivatives
11/30/2005EP1599481A1 6-substituted imidazopyrazines
11/30/2005EP1599480A1 Substituted hexahydropyrazino(1,2-a)pyrimidin-4,7-dion derivatives, method for the production and use thereof as medicaments
11/30/2005EP1599479A1 Substituted imidazotriazines
11/30/2005EP1599465A1 Substituted n-aryl nitrogen heterocycles
1 ... 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 ... 573